VCM
CAPR icon

Voleon Capital Management’s Capricor Therapeutics CAPR Stock Holding History

Voleon Capital Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$407K Buy
+13,382
New +$357K 0.01% 612
2025
Q4 		– Sell
-43,147
Closed -$311K – 816
2025
Q3 		$311K Buy
+43,147
New +$318K 0.01% 709

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Voleon Capital Management's CAPR Position: Q1 2026 in Review

Voleon Capital Management opened a new position in Capricor Therapeutics (CAPR) in Q1 2026: 13,382 shares worth $407K. The stake represents 0.01% of the portfolio and ranks #612 among its holdings. This is a return to the name: Voleon Capital Management previously reported a position in CAPR as recently as Q3 2025.

Voleon Capital Management first reported a position in CAPR in Q3 2025 and has held it in 2 quarters since. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Voleon Capital Management held 13,382 shares of Capricor Therapeutics worth $407K as of Q1 2026.
  • Capricor Therapeutics was a new Voleon Capital Management position in Q1 2026.
  • Capricor Therapeutics made up 0.01% of Voleon Capital Management's portfolio in Q1 2026, its #612 holding.
  • Voleon Capital Management first reported a position in Capricor Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.